A Retrospective Survey of Molecular, Cytogenetic, and Immunophenotype Data of Patients with Acute Lymphoblastic Leukemia in Northeast Iran

Publish Year: 1398
نوع سند: مقاله ژورنالی
زبان: English
View: 73

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_MISJ-10-3_002

تاریخ نمایه سازی: 25 آبان 1402

Abstract:

Background: Excess proliferation of blood cells may lead to leukemia, which is associated with structural and numerical chromosomal aberrations. Cytogenetic findings of acute lymphoblastic leukemia can be applicable in diagnosis, prognosis, and treatment selection for patients. In the present study we have evaluated molecular, cytogenetic, and immunophenotypic findings in acute lymphoblastic leukemia patients from Mashhad, a city in Northeast Iran. Methods: This cross-sectional study enrolled ۱۲۴ patients with acute lymphoblastic leukemia during ۲۰۱۵-۲۰۱۷. Two expert hematopathologists confirmed the diagnosis of acute lymphoblastic leukemia in patients’ peripheral blood and bone marrow smears. Molecular tests that included t(۴;۱۱), t (۱;۱۹), t (۹;۲۲)-۱۹۰, and t (۱۲;۲۱) were done by reverse transcriptase real-time quantitative PCR. We performed karyotyping and immunophenotyping of the bone marrow samples. The data were analyzed by SPSS v.۱۷. Results: Mean age of studied cases was ۲۰.۰۱ years. Participants consisted of ۶۴% males and ۳۶% females. Cytogenetic results showed that ۲۳.۳۷% of participants had a normal karyotype; the other participants had the following abnormalities: hyperdiploidy (۱۲.۰۶%), hypodiploidy (۲۱.۵۵%), pseudodiploidy (۲۴.۱۳%), and high hyperdiploidy (۱۸.۱۰%). Molecular analysis of karyotype patterns indicated that ۱۴% of the acute lymphoblastic leukemia patients had the t(۱۲;۲۱), ۹% with t(۱;۱۹), ۲.۵% with t(۴;۱۱), and ۲.۵% had the t(۹;۲۲). Conclusion: The unique findings of the present study were the presence of previously unreported novel abnormalities. These findings might be useful for oncologists and hematologists in predicting outcome, remission, survival, and treatment response in acute lymphoblastic leukemia patients.

Keywords:

Acute lymphoblastic leukemia (ALL) , Chromosomal abnormality , Cytogenetic

Authors

Seyyede Fatemeh Shams

Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Hossein Ayatollahi

Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Mohammadhadi Sadeghian

Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Sepide Shakeri

Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Zahra Rezaei Dezaki

Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Mojhgan Amirpour

Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran